|Articles|February 1, 2016
- Pharmaceutical Executive-02-01-2016
- Volume 36
- Issue 2
Pharmaceutical Executive, February 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 10 years ago
Life and Lipitor: Pfizer's Traci Medford-Rosowabout 10 years ago
The Staying Power of Emerging Marketsover 10 years ago
Canada's Rx&D: Fresh Start for a New Eraover 10 years ago
Pharma dot-gov: A New Business Modelover 10 years ago
The Creative Impulse: Defending Pharma and Health DTCover 10 years ago
Securing Cipla’s Futureover 10 years ago
Country Report: South AfricaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Angelini Pharma Enters $ 4.1 Billion Agreement to Acquire Catalyst Pharmaceuticals
2
Strengthening the Generic Drugs Supply Chain
3
Pharma M&A Roundup: Bayer to Acquire Perfuse Therapeutics, Madrigal Enters Licensing Agreement for ARO-PNPLA3
4
What Elements is the Conversation About Bringing Pharma Manufacturing Home Missing?
5